BioSpace News Archive

Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced that the company will present preclinical data highlighting the potential of its lead small molecule product candidate, ABX-002, as a treatment for neurodegenerative diseases at the American Academy of Neurology (AAN) Annual meeting.

DBV Technologies S.A., a clinical-stage specialty biopharmaceutical company, reported financial results for the full year of 2021.

Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Histogen’s financial results for the fourth quarter and year ended December 31, 2021 will be released after the close of market on Thursday, March 10, 2022.

CooperCompanies announced financial results for its first quarter of fiscal year 2022, which ended January 31, 2022.

A live audio webcast of the presentation will be available on the IQVIA Investor Relations website

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, today announced it will report its financial results from the fourth quarter and full year ended December 31, 2021, after the financial markets close on Thursday, March 10, 2022.

KalVista Pharmaceuticals, Inc., announced that the compensation committee of KalVista’s board of directors granted one newly-hired employee inducement options to purchase an aggregate of 5,000 shares of KalVista common stock on March 1, 2022 as inducement material to such employee entering into employment with KalVista.

Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and webcast on March 10, 2022 at 4:30 pm ET (1:30 pm PT) to provide a business update and report fourth quarter and full year 2021 financial results.

MiNK Therapeutics, Inc. announced it will release its independent fourth quarter and full year 2021 financial results and a business update before the market opens on Friday, March 18, 2022.

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Chairman and Chief Executive Officer, Kevin Hrusovsky will present virtually at The Cowen 42nd Annual Health Care Conference on March 9, 2022 at 9:50 a.m., EST.